Document is current
Any future updates will be listed below
-
Authors
Suto, Hironobu https://orcid.org/0000-0001-8476-3985
Oshima, Minoru
Ando, Yasuhisa
Matsukawa, Hiroyuki
Takahashi, Shigeo
Shibata, Toru
Kamada, Hideki
Kobara, Hideki
Okuyama, Hiroyuki
Tsuji, Akihito
Kumamoto, Kensuke
Okano, Keiichi
- License Information
-
More Information
Article History
Received: 27 June 2025
Accepted: 28 October 2025
First Online: 18 November 2025
Disclosure
: Hiroyuki Okuyama received lecture fees from Novartis Pharma, TAIHO Pharma, AstraZeneca, Chugai Pharmaceutical Co., Ltd., Incyte Biosciences Japan, Gardant Health Japan, MIYARISAN Pharmaceutical Co, Otsuka Pharmaceutical Factory, Inc, Merck & Co., Inc, and NIHON Servier. Akihito Tsuji has relevant financial activities outside the submitted work with Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan Co., Ltd., Merck Biopharma Co., Ltd., Sanofi Corporation, and Bristol-Myers Squibb.
